Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters.

Gall, Astrid; Kaye, Steve; Hué, Stéphane; Bonsall, David; Rance, Richard; Baillie, Gregory J; Fidler, Sarah J; Weber, Jonathan N; McClure, Myra O; Kellam, Paul

Gall, Astrid; Kaye, Steve; Hué, Stéphane; Bonsall, David; Rance, Richard; Baillie, Gregory J; Fidler, Sarah J; Weber, Jonathan N; McClure, Myra O; Kellam, Paul.

Affiliation

Gall A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Retrovirology ; 10: 8, 2013 Jan 18.

Article in En | MEDLINE | ID: mdl-23331949

Subject(s)

Antiretroviral Therapy, Highly Active; Genes, env; Genetic Variation; HIV Antibodies/blood; HIV Envelope Protein gp120/genetics; HIV Infections/drug therapy; HIV-1/genetics; Peptide Fragments/genetics; Cohort Studies; Cross-Sectional Studies; HIV Infections/virology; HIV-1/drug effects; HIV-1/immunology; Humans; Mutation; Sequence Analysis, DNA/methods; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Genetic Variation / HIV Antibodies / Genes, env / HIV Envelope Protein gp120 / HIV Infections / HIV-1 / Antiretroviral Therapy, Highly Active Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Retrovirology Journal subject: VIROLOGIA Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google